# Phase 1 Intrathecal Topotecan for Neoplastic Meningitis

> **NCT00674674** · PHASE1 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 22 (actual)

## Conditions studied

- Neoplastic Meningitis

## Interventions

- **DRUG:** Topotecan
- **DRUG:** Topotecan
- **DRUG:** Topotecan

## Key facts

- **NCT ID:** NCT00674674
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2010-08
- **Final completion:** 2010-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00674674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00674674, "Phase 1 Intrathecal Topotecan for Neoplastic Meningitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00674674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*